Breast Milk Profiling Reveals Seven Molecules Linking Maternal Nutrition to Infant Growth

On October 8, 2026, the journal Science published a pair of landmark studies that fundamentally redefine how breast milk functions. Rather than acting as a simple pass-through for a mother's diet, human milk operates as a highly regulated biological system that actively buffers infant nutrition against external deficits.[5][6]

The research, led by the International Milk Composition Consortium, analyzed 1,543 milk samples from more than 1,000 mother-infant pairs across Canada, Pakistan, and Burkina Faso. Investigators profiled more than 25,000 distinct compounds, including macronutrients, vitamins, and immune factors, to map the lactating mammary gland's internal processes.[2][6]

"Human milk gives us a rare, noninvasive window into the biology of the lactating mammary gland," said Liat Shenhav, an assistant professor at NYU Grossman School of Medicine and senior author of the molecular profiling study. "By looking at molecular patterns across diverse populations, we can begin to identify shared features of mammary function."[3]

Identifying the molecular bridge

The NYU-led team successfully isolated seven candidate molecules that directly link a mother's nutritional status to her infant's growth. These biomarkers provide a measurable readout of the mammary gland's internal processes, mapping milk composition onto three distinct functional states of the lactating breast.[1][5]

Those three interconnected states include milk synthesis and secretion, the maintenance of the epithelial barrier and tissue remodeling, and the gland's immune and repair activity. By tracking the seven molecules, researchers can observe how the mammary tissue regulates what passes from the maternal bloodstream into the milk.[3][5]

One specific mechanism the researchers identified is the pantothenic-CoA-C5 metabolic pathway. This route appears to serve as a primary biological bridge, translating maternal metabolic health into the specific milk composition that drives early childhood development and infant weight gain.[1][5]

"One plausible route linking maternal nutrition to mammary metabolism in our data is via the pantothenic-CoA-C5 metabolic pathway," said April Jauhal, first author of the study at NYU Grossman School of Medicine. "We are currently investigating the functional role of this pathway in mammary biology and lactation."[1]

The findings shift the scientific understanding of lactation from a static nutritional delivery system to a dynamic maternal-infant interface. During pregnancy, the mammary gland undergoes extensive hormonal differentiation and metabolic programming, and these new biomarkers allow researchers to track that programming noninvasively after delivery.[3][5]

Dietary buffering and supplementation

A companion study, led by Trenton Dailey-Chwalibóg of Ghent University and AFRICSanté, harmonized data from three randomized nutritional trials to see how maternal diets actually alter milk. The trials included the MISAME-III study in Burkina Faso, Mumta-LW in Pakistan, and ELICIT in Tanzania.[6]

The team discovered that while certain components shift, the vast majority of milk's structural and immune core remains remarkably stable regardless of what the mother eats. Postnatal supplementation with balanced energy-protein or nicotinamide successfully raised B-vitamin and selenium concentrations in the mothers' milk.[6]

In addition to B vitamins and selenium, the researchers observed distinct shifts in the composition of triglycerides, the fats that serve as a primary energy source for the growing infant. By mapping these lipid profiles, the consortium proved that targeted dietary changes can directly enhance the caloric density of the milk.[6]

However, macronutrients, human milk oligosaccharides, bioactive proteins, and the milk microbiome were physiologically buffered. These critical components resisted changes induced by the maternal diet, demonstrating that the mammary gland prioritizes maintaining a consistent immune and structural profile for the infant.[6]

"The studies show that human milk is neither fixed nor simply a reflection of what a mother eats," said Shenhav. "Some components respond to maternal nutrition, while others remain stable or appear to reflect broader biological states within the mammary gland."[1]

Designing targeted interventions

The clinical implications are particularly significant for regions where maternal undernutrition is widespread. The trials demonstrated that postnatal nutritional supplementation improved infant growth primarily in the most undernourished cohorts, proving that targeted maternal diets can correct specific developmental deficits.[6]

In a subset of the MISAME-III trial, blood samples from both mothers and infants showed concordant micronutrient changes following the supplementation. This confirmed that the elevated B vitamins and selenium in the breast milk were successfully absorbed into the infants' bloodstreams, directly impacting their systemic health.[6]

Because the research isolates exactly which vitamins and triglycerides respond to supplementation, public health officials can now design maternal vitamins that reliably reach the infant. This precision replaces the previous assumption that any maternal dietary improvement would automatically translate into better milk across the board.[6]

The International Milk Composition Consortium, funded by the Bill & Melinda Gates Foundation, involved more than 20 researchers from 13 organizations across six countries. Their combined dataset represents one of the most comprehensive multi-omics profiles of human milk ever assembled.[1][6]

Moving forward, the NYU team is developing a computational framework to test potential nutritional bottlenecks that constrain milk production. By modeling the vitamin B5 and coenzyme A pathways, they hope to find exact intervention points to support mothers struggling with lactation and low milk supply.[1][3]

Researchers are also expanding their analysis to colostrum, the thick, nutrient-dense milk produced immediately after birth. Tracking these seven molecular biomarkers through the transition from pregnancy to mature lactation will clarify how the mammary gland establishes its protective barrier in the crucial first days of life.[1][3]

The discovery of these seven molecules provides a concrete biological target for future pediatric research. By treating the mammary gland as an active regulatory organ rather than a passive vessel, scientists can better protect the critical early-life development window for infants worldwide.[3][5]